Department of Research and Innovation
Current internal research studies
- Currently there is no Active Research Study
Clinical trials
- 1HREC - Information for patients
What is a Human Research Ethics Committee?
Research proposals involving human participants must be reviewed and approved by a Human Research Ethics Committee (HREC) before the research can commence. The HREC is established by and advises an institution or organisation, in this case CDD, regarding ethical approval for research projects.
What is the role of a Human Research Ethics Committee?
“To protect the welfare and rights of the participants in research and the primary responsibility of each member is to decide, independently, whether in his or her opinion, the conduct of each research proposal submitted to the HREC will protect participants.” (NHMRC – National Statement on Ethical Conduct in Research Involving Humans), whilst considering the principles of ethical conduct:
- Integrity – honest and ethical conduct of research
- Regard for welfare, rights, beliefs, perceptions etc
- Responsibility to minimise risks of harm or discomfort
- Respect for dignity and wellbeing
- Consent MUST be obtained before patient participation
- Research merit and safety must be demonstrated
Therefore,
- By providing objective and informed opinions about new research protocols, the HREC aims to protect the rights and welfare of participants in clinical trials.
- In ensuring the safety of patients in clinical trials, the HREC also facilitates research that will benefit the worldwide community;
- The HREC protects the integrity of research and development into gastroenterological disorders and safeguards the wellbeing of patients participating in clinical trials at the CDD.
Who are members of an HREC?
The members of a HREC must be representative of the community. As such, a minimum composition is required:
- Chairperson: The chairperson has the capacity to carry out HREC’s obligations under the National Statement and has had suitable experience.
- Two lay people: One man and one woman who have no affiliation with the institution and do not currently engage in medical, scientific, legal or academic work.
- One person with knowledge of, and current experience in, the professional care, counselling or treatment of people (for example, a nurse or allied health professional).
- One person who performs a pastoral care role in a community (for example an Aboriginal elder, a minister of religion).
- One lawyer, where possible one who is not engaged to advise the institution.
- Two people with current research that is relevant to the research proposals to be considered at the meetings they attend.
If you wish to make a complaint regarding the ethical conduct of the staff, please email research@cdd.com.au.
- 2Clinical Trials - What are they? Why do we need them?
What is a Clinical Trial?
- A study conducted to test if a particular medical treatment / device is safe and effective in patients.
- Most trials are for medicine, but can be for any form of treatment or medical device.
- Some trials involve testing completely new treatments, others study the safety and effectiveness of slight changes in already existing treatments, whilst others are run to determine if an existing treatment can be safely used to treat diseases other than those for which the drug was first developed.
Why are Clinical Trials so important?
- They allow doctors to understand how a new medicine works.
- They help doctors assess if the new medicine is safer and more effective than existing medicines.
- They provide information regarding the best way to use particular treatments.
- They provide information on the benefits and risks of existing treatments.
How are Clinical Trials conducted?
A clinical trial falls into one of four phases:
Phase One Trials:
- Typically involve a small number of healthy people. This is because any adverse effects of the treatment being trialled are easier to see if the patient is healthy.
- Are performed in order to determine the basic characteristics of the medicine. For example:
- The range of safe doses. .
- Whether the medicine should be given orally or via another route.
- The way in which the medicine interacts with the human body.
- Any side effects caused by increased doses of the medicine.
Phase Two Trials:
- Involve a larger group of patients (no more than a few hundred).
- Address the effectiveness of the medicine/device being studied.
- Provide additional information on the safety of the medicine and the proper dosage required.
- Gather more information on the short-term risks associated with the treatment.
Phase Three Trials:
- Are much larger studies involving many hundreds, or thousands, of patients.
- Compare the effectiveness of the new treatment against pre-existing treatments for the same disease.
- Promote the detection of less common side effects.
- May result in the licensing of the medicine by the Therapeutic Goods Administration (TGA) of Australia (or by similar agencies around the world) if the medicine has been shown to be safe and effective.
Phase Four Trials:
- Are carried out after the medicine has been released into the market.
- Are conducted to learn more about the medicine.
- Determine the impact of the medicine in long-term use.
- May find rare, but important side effects that were not detected in earlier trials. If these are serious, it can lead to the removal of the medicine from the market.
Who runs a Clinical Trial?
- A team of people from a wide variety of backgrounds help conduct a clinical trial.
- The team is usually led by a doctor, who is known as the Principal Investigator.
- Other doctors, as well as pharmacists, nurses and scientists assist.
- The clinical trial team is responsible for assessing the health of the participants before the trial begins and monitor the participant’s health and wellbeing during and after the trial.
Who can participate in a Clinical Trial?
For every clinical trial, there are a set of guidelines which specify who can participate in the trial. These include:
- Specific inclusion criteria which participants must meet before they can enter the trial. These commonly include
- Specific exclusion criteria which potential participants must not meet in order to be eligible for the trial.
- The inclusion and exclusion criteria commonly include factors such as age, disease severity and previous treatments.
These guidelines are set in place in order to minimize any study associated risks to the patient.
If you are found ineligible for a study – it is for your own safety!
Why participate in a Clinical Trial?
There are many benefits to be gained from participating in a clinical trial. For patients these include:
- Gaining access to treatments that are otherwise unavailable to the general public.
- Obtaining the treatment at no cost during the clinical trial.
- Obtaining access to medical care that is associated with the trial.
- Participating in the development of new treatments that may later aid many people.
In addition to the benefits available from participating in a clinical trial, there are also risks associated with being a participant in a study. These include:
- The new treatment being ineffective.
- Side effects that may result from the use of the new treatment.
- More frequent visits to the doctor, hospital or medical centre in order to participate in the study.
- Undergoing invasive procedures, such as blood tests.
Finally, the patient also has responsibilities when participating in a clinical trial. For example, committing to regular clinic visits or having to maintain a diary of your condition.
What is the role of the Ethics Committee?
- Clinical trials must be approved by an Ethics Committee before they can begin.
- The main purpose of the Ethics Committee is to safeguard the interests of the patients involved in the study.
- The Ethics Committee itself is governed by a set of guidelines set by the National Health and Medical Research Council (NHMRC). These guidelines ensure that the interests of the participants are being protected.
- The members of the Ethics Committee come from a wide range of backgrounds. These include:
- Medical professionals
- Scientists
- Lawyers
- Ministers of Religion
- Laypeople
- Member diversity ensures that a range of viewpoints are captured when clinical trials are reviewed.
- The doctor / medical centre / hospital conducting the clinical trial must report their procedures to the Ethics Committee. They must also report any risks believed to be associated with the trial and any changes to the study protocol. If the risks involved in the trial are greater than the benefits the patients receive, then the study may be rejected, or terminated, by the Ethics Committee.
What are the responsibilities of the Sponsors and Researchers?
- All clinical trials have a Sponsor.
- The Sponsor of a clinical trial is the individual, company, research institution or organisation that funds a research study.
- The Sponsor takes responsibility for beginning and managing a clinical trial.
- Researchers on the other hand, are employed by the Sponsor and are responsible for carrying out the clinical trial.
- Both the Sponsors and the Researchers who conduct the clinical trial must ensure that:
- Regulatory and ethical guidelines that govern all clinical trials are followed.
- The Ethics Committee has given approval to conduct the clinical trial.
- The resources required to conduct the clinical trial are provided, including funding, staff and facilities.
- Appropriate methods of compensation are available should serious injury result from participation in a clinical trial.
- A Sponsor may transfer any or all of their clinical trial-related duties to a Contract Research Organisation. However, the responsibility for the quality of the clinical trial still remains with the Sponsor.
Commonly Used Research Terms
Research terms that are often used when describing a clinical trial include:
Adverse Events: Undesirable side effects that may occur in a clinical trial, which may or may not be a result of taking a study medicine.
Audits: Throughout the duration of a clinical trial and after the trial has been completed, audits may be conducted. These routine checks are performed to ensure that the trial is conducted responsibly and ethically.
Informed Consent: Participants must give fully informed voluntary written consent before they are able to take part in a study. Before enrolling in a trial, participants discuss the study with the doctor. This consent form indicates that participants are fully informed and are taking part in the study of their own free will.
Placebo: A placebo is an inactive substance that may be given to the control group of patients in a study. This substance looks like a medicine but does not contain any medicine.
Protocol: A Clinical Trial Protocol is a detailed description of the design and procedures of a research study. The protocol provides information on what is being researched, why it is being researched, how the research will be conducted and when the research will begin and end.
TGA (Therapeutic Goods Administration): The TGA is an Australian organisation that regulates the testing, manufacture and use of medicines and devices. Medicines and medical devices must be approved by the TGA before they can be made available commercially to the public.
Factors Effecting the Validity of a Clinical Trial
Many factors can influence the effectiveness of a clinical trial and whether the results of the trial are valid. These can include:
Blinding: Blinding minimises the chance of biased reporting when participants or doctors discuss the effects of the treatment. Double-blind procedures lead to a more effective study.
Single-blind studies: In single blind studies the participant is unaware of which treatment they are receiving but the doctors and researchers are aware of the treatment that the patient is receiving.
Double-blind studies: In double-blind studies both the doctor and the participant are unaware of which of the listed study treatments the participant is receiving.
Control Groups: In clinical trials, there are usually at least two groups. One is an experimental group which is given the new treatment being studied. The other is a control group which is given a standard treatment currently available on the market. If standard treatment is unavailable, the control group is given a placebo (a look-alike pill with no active medicine). Control groups help ensure that the outcomes of the new treatment are not biased by patients’ beliefs.
Randomisation: Randomised trials are clinical trials where participants are assigned to a treatment group on a random basis. This means that patients are assigned to groups irrespective of their age, gender, medical condition or any other similar factors. These sorts of trials are more reliable.
Sample size: Sample size refers to the number of patients involved in the study. Usually, the more people involved in a trial, the more reliable the results of the study will be.
